Guillem Laporta
Direttore/Membro del Consiglio presso Varmx BV
Provenienza dei contatti di primo grado di Guillem Laporta
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
Andera Partners SCA
 Andera Partners SCA Investment ManagersFinance Andera Partners SCA (Andera Partners) is a private equity firm founded in 2001 by Pierre-Michel Passy. The firm is headquartered in Paris, France.
38
| Private Company | Investment Managers | 38 |
Universitat Pompeu Fabra
24
| College/University | Other Consumer Services | 24 |
Ysios Capital Partners SGEIC SA
 Ysios Capital Partners SGEIC SA Investment ManagersFinance Ysios Capital Partners SGEIC SA (Ysios Capital) is a venture capital firm founded in 2007 by Joël Jean Pierre Jean-Mairet, Julia Salaverría Monfort and Josep Lluís Sanfeliu Benet. The firm is headquartered in San Sabastian, Spain with additional office in Barcelona.
21
| Private Company | Investment Managers | 21 |
Universitat Autònoma de Barcelona
12
| College/University | Other Consumer Services | 12 |
Varmx BV
 Varmx BV BiotechnologyHealth Technology VarmX BV is a spin-off from Leiden University Medical Center (LUMC) founded in 2016 by Professor Pieter Reitsma, a world-leading expert in hemostasis and thrombosis. VarmX is based in Leiden, NL. The Dutch company's lead compound, VMX-C001, is a modified recombinant blood factor X developed for the treatment of severe spontaneous bleeding and for the prevention of bleeding during urgent surgery in patients taking oral factor Xa inhibitors (FXa DOACs) as anticoagulation therapy. The company is supported by a strong syndicate of investors. Jan K. Öhrström has been the CEO of the company since 2018.
8
| Holding Company | Biotechnology | 8 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Guillem Laporta tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
| NOVO NORDISK A/S | Pharmaceuticals: Major | Sales & Marketing Corporate Officer/Principal Corporate Officer/Principal | |
| H. LUNDBECK A/S | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| TIGENIX NV | Medical Specialties | Director/Board Member Director of Finance/CFO | |
| AURA BIOSCIENCES, INC. | Biotechnology | Director/Board Member Director/Board Member | |
ODDO BHF Private Equity SA
 ODDO BHF Private Equity SA Investment ManagersFinance ODDO BHF Private Equity SA operates as a private equity firm. The company was founded on December 8, 1993 and is headquartered in Paris, France. | Investment Managers | Director of Investments Director of Investments Private Equity Analyst Private Equity Investor | |
TCR Capital SAS
 TCR Capital SAS Investment ManagersFinance TCR Capital SAS is an independent private equity investment firm wholly-owned by management. Based in Paris, TCR is a lower mid-market specialist established in 1989 as the European office of US-based Quilvest. The firm launched their first fund in 1996, and in 2000 restricted their focus to France. As the management gradually increased their shareholding, the firm became independent in 2003 and wholly-owned in 2007. TCR manages a series a private equity funds. Their clients are French and European institutions and family offices. | Investment Managers | Director/Board Member Corporate Officer/Principal | |
| INSEAD | College/University | Masters Business Admin Masters Business Admin | |
Roche Glycart AG
 Roche Glycart AG Pharmaceuticals: MajorHealth Technology Roche Glycart AG discovers and develops drugs. It is active in the research and development of new potent antibody-based products for the treatment of unmet clinical needs such as cancer. It uses its proprietary set of technologies to endow therapeutic antibodies. The company has developed glycoengineering technology (GlycoMAb) to boost a natural mechanism of action of therapeutic antibodies developed to mediate target cell killing. The company was founded in 2000 and is headquartered in Zurich, Switzerland. | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal | |
| University of Copenhagen | College/University | Doctorate Degree Doctorate Degree Graduate Degree | |
| University of Barcelona | College/University | Doctorate Degree Undergraduate Degree Graduate Degree | |
| University of Deusto | College/University | Masters Business Admin Masters Business Admin | |
| University of Bocconi | College/University | Doctorate Degree Graduate Degree Undergraduate Degree | |
| EM Lyon Business School | College/University | Graduate Degree Graduate Degree Graduate Degree | |
| Université Paris Dauphine-PSL | College/University | Graduate Degree Undergraduate Degree | |
Sogetrel SAS
 Sogetrel SAS Specialty TelecommunicationsCommunications Sogetrel SAS engages in the design, deployment, and maintenance of network infrastructures and digital communication solutions. It offers turnkey solutions for the deployment, connection, commissioning of telecommunication networks, video surveillance, access control, intrusion detection, and advice and assistance in the implementation of smart city projects. The company was founded in 1985 and is headquartered in Issy-les-Moulineaux, France. | Specialty Telecommunications | Director/Board Member Director/Board Member | |
| École des Hautes Études Commerciales de Paris | College/University | Graduate Degree Undergraduate Degree Graduate Degree Undergraduate Degree | |
| ESCP Europe Campus Paris | College/University | Graduate Degree Graduate Degree Graduate Degree Undergraduate Degree Graduate Degree | |
| Universite Paris Est Creteil Val De Marne | College/University | Graduate Degree Undergraduate Degree | |
Forbion Capital Partners Management Holding BV
 Forbion Capital Partners Management Holding BV Investment ManagersFinance Forbion Capital Partners Management Holding BV (Forbion) is a Netherlands-based venture capital firm which was founded by Bart Bergstein. Headquartered in Naarden, the firm specializes in late-stage and early-stage clinical development programs to optimize the commercial potential of their investee company's technologies. | Investment Managers | Private Equity Investor Private Equity Investor | |
Cellerix SA
 Cellerix SA Pharmaceuticals: GenericHealth Technology Founded in 2004, Cellerix is a biopharmaceutical company that develops innovative treatments based on cell therapy. Cellerix was founded within the Genetrix Group, group of biotechnology companies specialising in biomedicine. The Genetrix Group began its activities in 2001 at the National Centre for Biotechnology (CNB), which belongs to the Spanish Research Council (CSIC). One of the main objectives of Genetrix is to convert basic research results into therapeutic realities. Cellerix is leading the development of a new generation of medicines using expanded adult stem cells from adipose tissue (eASCs). Development is at a clinically advanced stage and the results from clinical trials in Phase I and II have been very promising. Obtaining these eASCs has big advantages because the process makes use of tissue that is almost always discarded from surgical procedures such as liposuction. eASCs have the capacity to activate physiological repair mechanisms through interaction with affected tissue. This technology represents a revolution in the treatment of some diseases that cannot satisfactorily be cured at present. Cellerix is working actively to adapt this new therapeutic strategy to treat autoimmune diseases such as inflammatory bowel disease. The main goal of the company is to market new tools for treating these diseases, which have a considerable negative impact of the quality of life of the sufferers. Cellerix also researches and develops medicines in other areas such as the development of skin equivalents, which are initially intended for the treatment of hereditary diseases such as epidermolysis bullosa. | Pharmaceuticals: Generic | Chairman Director of Finance/CFO | |
| CAIXABANK, S.A. | Regional Banks | Director/Board Member Corporate Officer/Principal | |
| Universidad Autónoma de Madrid | College/University | Doctorate Degree Undergraduate Degree Undergraduate Degree | |
Sanifit Therapeutics SA
 Sanifit Therapeutics SA BiotechnologyHealth Technology Sanifit Therapeutics SA develops pharmaceuticals for calcification disorders. Its pipeline consists of treatments for calcification disorders, such as calciphylaxis and osteoporosis. The company was founded by Felix Grases in 2004 and is headquartered in Palma de Mallorca, Spain. | Biotechnology | Director/Board Member Director/Board Member Founder Director/Board Member | |
| ARGENX SE | Pharmaceuticals: Other | Director/Board Member Director/Board Member Director/Board Member | |
Unaferm SAS
 Unaferm SAS Building ProductsProducer Manufacturing Unaferm SAS manufactures and installs shutters and windows. Its products include into plus window, swing shutter aluminum, lumia door entry, polyvinyl chloride, wood decor window, winding garage, roller shutter small case, toirol and roof window alpina. The company was founded by Maurice Heimerdinger in 1969 and is headquartered in Aspach, France. | Building Products | Director/Board Member Director/Board Member | |
Prenax SASU
 Prenax SASU Miscellaneous Commercial ServicesCommercial Services Prenax SASU develops subscription management software. It offers its solutions to the banking, insurance, legal counseling, healthcare, industrial, education, media, government, and research sectors. The company was founded in 2000 and is headquartered in Courbevoie, France. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| BIOM'UP | Medical Specialties | Chairman Director/Board Member | |
| L'école d'économie de Toulouse | College/University | Graduate Degree Undergraduate Degree | |
STAT-Dx Life SL
 STAT-Dx Life SL Medical SpecialtiesHealth Technology STAT-Dx Life SL focuses on the development, manufacturing and commercialization of diagnostic solutions for fast and accurate diagnostic results of infectious diseases and critical care. It solution offers DiagCORE Cartridge, for sample and analyzation of cell material, nucleic acid purification, amplification and hybridization process. The company was founded by Jordi Cabrrera Fabra and Rafael Bru Gibert in 2010 and is headquartered in Barcelona, Spain. | Medical Specialties | Director/Board Member Director/Board Member | |
Medlumics SL
 Medlumics SL Medical SpecialtiesHealth Technology Medlumics SL provides medical imaging diagnostics services. It specializes in optically guided medical devices. The firm’s proprietary integrated optics platform technology combines optical and electrical components in a miniature chip, enabling for the first time complex multi view optical probes of the size of a grain of rice and ultra-portable, hand-held OCT systems that produces real-time images. The company was founded by Eduardo Margallo Balbás and Jose Luis Rubio Guivernau on April 3, 2009 and is headquartered in Tres Cantos, Spain. | Medical Specialties | Director/Board Member Director/Board Member | |
Technologies Broadcasting System SAS
 Technologies Broadcasting System SAS Packaged SoftwareTechnology Services Technologies Broadcasting System SAS provides advertising, media and communication services. The company was founded by Patrick Henrotte in 1987 and is headquartered in Bailly, France. | Packaged Software | Director/Board Member Director/Board Member | |
Inbiomotion SL
 Inbiomotion SL Medical SpecialtiesHealth Technology Inbiomotion SL designs and develops diagnostic assays. It focus on genetic biomarkers, which predict the bone-specific metastases in cancer patients. The firm develops biomarker in breast cancer primary tumors for predicting the bone relapse. The company was founded by in 2010 and is headquartered in Barcelona, Spain. | Medical Specialties | Chairman Director/Board Member | |
Prexton Therapeutics SA
 Prexton Therapeutics SA Pharmaceuticals: MajorHealth Technology Prexton Therapeutics SA operates as a biopharmaceutical company which develops novel therapeutic compounds as a new treatment for Parkinson’s disease and other brain disorders. The company was founded by Francois Conquet in 2012 and is headquartered in Geneva, Switzerland. | Pharmaceuticals: Major | Director/Board Member Founder | |
Rainier Therapeutics, Inc.
 Rainier Therapeutics, Inc. BiotechnologyHealth Technology Rainier Therapeutics, Inc. operates as a biotechnology company that develops a targeted biologic for the potential treatment of metastatic bladder cancer. It provides Vofatamab, an antibody that is focused on the fibroblast growth factor of bladder and other cancer. The company was founded by Stephen Lau and is headquartered in San Leandro, CA. | Biotechnology | Director/Board Member Director/Board Member | |
Walor International SAS
 Walor International SAS Metal FabricationProducer Manufacturing Walor International SAS manufactures precision machine components for the automotive industry. Its expertise includes cold forging, machining, and thermal treatment. The company was founded by Jacky Lorin and Jim Wallart in June 1993 and is headquartered in Lege, France. | Metal Fabrication | Director/Board Member Director/Board Member Director/Board Member | |
Onward Medical SA
 Onward Medical SA BiotechnologyHealth Technology ONWARD Inc develops medical devices. It also provides stimulation system to rehabilitate individuals with spinal cord injury. The company was founded by Jocelyn Bloch, Sjaak Deckers, Grégoire Courtine, and Vincent Delattre in December 2014 and is headquartered in Lausanne, Switzerland. | Biotechnology | Chairman Director/Board Member | |
Ellisphère SAS
 Ellisphère SAS Data Processing ServicesTechnology Services Ellisphère SAS develops and provides data science and analytics solutions. It specializes in the collection and processing of financial, economic, and legal information for investment professional. The company was founded in 2006 and is headquartered in Nanterre, France. | Data Processing Services | Director/Board Member Director/Board Member | |
| ARCUS BIOSCIENCES, INC. | Biotechnology | Director/Board Member Director/Board Member | |
Naitways SAS
 Naitways SAS Information Technology ServicesTechnology Services Naitways SAS is a French company that provides customized infrastructure services to improve efficiency, security, and agility. The company is based in Boulogne-Billancourt, France. The company's team of experts assists clients in managing and evolving their infrastructure. | Information Technology Services | Director/Board Member Director/Board Member | |
SpliceBio SL
 SpliceBio SL BiotechnologyHealth Technology SpliceBio SL is a genetic medicines company based in Barcelona, Spain. The Spanish company harnesses its proprietary protein splicing platform to develop the next generation of gene therapies. SpliceBio's platform offers the potential to address diseases that currently cannot be treated with gene therapies because the necessary gene is too large to be delivered by -associated virus (AAV) vectors. The company's lead program targets Stargardt disease, a genetic eye disease that causes vision loss in children and adults. SpliceBio's platform is based on technology developed in the Muir lab at Princeton University after more than 20 years of pioneering intein and protein engineering research. The company was founded by Dominguez Silvia Frutos, Miquel Vila-Perelló, and Miquel Vila-Perelló has been the CEO since incorporation. | Biotechnology | Director/Board Member Director/Board Member | |
Asabys Partners SGEIC SA
 Asabys Partners SGEIC SA Investment ManagersFinance Asabys Partners SGEIC SA (Asabys Partners) is an independent venture capital firm founded in 2019 by Clara Campàs-Moya and Josep Lluís Sanfeliu Benet. The firm is headquartered in Barcelona, Spain. | Investment Managers | Private Equity Investor Private Equity Analyst | |
Ona Therapeutics SL
 Ona Therapeutics SL Pharmaceuticals: MajorHealth Technology Ona Therapeutics SL is a biotech company based in Barcelona, Spain that specializes in discovering and developing therapeutic biologics targeting tumor metastatic-initiating cells and lipid metabolism. The Spanish company's focus is on developing novel therapies against advanced cancer. The company was founded in 2019 by Salvador Aznar Benitah and Valerie Liesbeth Brigitte Vanhooren, with Valerie Liesbeth Brigitte Vanhooren serving as CEO since incorporation. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| The Bank of Canada (Research Firm) | Investment Managers | Economist Economist | |
| ONWARD MEDICAL N.V. | Miscellaneous Commercial Services | Chairman Director/Board Member | |
| Escp Business School | College/University | Graduate Degree Graduate Degree | |
Synacktiv SAS
 Synacktiv SAS Information Technology ServicesTechnology Services Synacktiv SAS provides cyber security services. The company is based in Paris, France. The French company was founded in 2012 by Nicolas Collignon, Renaud Feil. Renaud Feil has been the CEO since 2012. | Information Technology Services | Director/Board Member Director/Board Member |
Statistiche
Distribuzione geografica
| Francia | 23 |
| Spagna | 13 |
| Svizzera | 5 |
| Danimarca | 4 |
| Stati Uniti | 4 |
Settori
| Health Technology | 20 |
| Consumer Services | 14 |
| Finance | 10 |
| Technology Services | 5 |
| Producer Manufacturing | 3 |
Posizioni
| Director/Board Member | 259 |
| Private Equity Investor | 82 |
| Graduate Degree | 73 |
| Corporate Officer/Principal | 61 |
| Undergraduate Degree | 54 |
Contatti più connessi
| Insiders | |
|---|---|
| Cristina Garmendia Mendizábal | 38 |
| Michael Hayden | 27 |
| Peter Andersen | 26 |
| John Paul de Koning | 21 |
| Pamela Klein | 19 |
| Casper Breum | 18 |
| Joël Jean-Mairet | 17 |
| Karen Wagner | 17 |
| Antoni Ribas | 15 |
| Carlos Paya | 14 |
| Pierre-Luc Wilain de Leymarie | 14 |
| Jan Öhrström | 13 |
| David Nicault | 13 |
| Laurent Fichter | 13 |
| David Lacey | 12 |
- Borsa valori
- Insiders
- Guillem Laporta
- Connessioni Società
